FDA Says Drug Companies May Be Abusing Petition Process
Pharmaceutical companies may still be filing so-called citizen petitions to delay approval of generic versions of their drugs, and the delays caused by those petitions are keeping the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article